Skip to content

Integra LifeSciences IART Specialty Surgery — Goodwill

Other segment segments

Tissue Reconstruction
$270.15M

Similar metrics at other companies

Radian Group logo
RDNSpecialty — Goodwill
$5M
Perrigo Company logo
PRGOSpecialty Care — Goodwill
$597.3M
Bausch + Lomb logo
BLCOSurgical — Goodwill
$456M+28.5%
CNA Financial logo
CNASpecialty — Goodwill
$117M0.0%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Goodwill
$366.31M0.0%
PFG
PFGCSpecialty — Goodwill
$133.4M0.0%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's specialty surgery — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's specialty surgery — goodwill?
Integra LifeSciences (IART) reported specialty surgery — goodwill of $343.1M in Q1 2026.
What does specialty surgery — goodwill mean?
This represents the carrying value of goodwill allocated to the Specialty Surgery segment, typically arising from past business acquisitions. It reflects the premium paid over the fair value of net identifiable assets, serving as a long-term indicator of historical M&A activity and potential impairment risk.